Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders

@article{Liebowitz1990ReversibleAI,
  title={Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders},
  author={M. Liebowitz and E. Hollander and F. Schneier and R. Campeas and L. Welkowitz and J. Hatterer and B. Fallon},
  journal={Acta Psychiatrica Scandinavica},
  year={1990},
  volume={82}
}
In addition to being effective in depressive disorders, monoamine oxidase inhibitors (MAOIs) have been shown to be effective in controlled studies of patient with panic disorder with agoraphobia, social phobia, atypical depression or mixed anxiety and depression, bulimia, posttraumatic stress disorder (PTSD) and borderline personality disorder. Uncontrolled case reports have noted MAOI efficacy in obsessive‐compulsive disorder (OCD), trichotillomania, dysmorphophobia and avoidant personality… Expand
Monoamine Oxidase Inhibitors
Monoamine oxidase inhibitors. A perspective on their use in the elderly.
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders
Alcohol and depression in panic disorder
  • U. Lepola
  • Psychology, Medicine
  • Acta psychiatrica Scandinavica. Supplementum
  • 1994
History repeats itself: pharmacodynamic trends in the treatment of anxiety disorders.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Forms of atypical depression and their response to antidepressant drugs
Differential response patterns to MAO inhibitors and tricyclics.
  • A. Nies
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 1984
Moclobemide and clomipramine in the treatment of depression
A case of social phobia with avoidant personality disorder treated with MAOI.
Antidepressant specificity in atypical depression.
An open trial of MAO inhibitors in bulimia.
...
1
2
3
4
5
...